Page last updated: 2024-12-07
n-acetylmethionine alpha-naphthyl ester
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
N-acetylmethionine alpha-naphthyl ester: RN given refers to (L)-isomer [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
| ID Source | ID |
|---|---|
| PubMed CID | 125816 |
| MeSH ID | M0075091 |
Synonyms (16)
| Synonym |
|---|
| n-acetylmethionine alpha-naphthyl ester |
| naphthalen-1-yl (2s)-2-acetamido-4-methylsulfanylbutanoate |
| 69975-69-5 |
| l-methionine, n-acetyl-, 1-naphthalenyl ester |
| ac-methionine-alpha-naphthyl ester |
| n-acetyl-l-methionine alpha-naphthyl ester |
| ac-met-alpha-naphthylester |
| ac-met-alpha-naphthyl ester |
| n-acetyl-l-methionine-1-naphthylester |
| n-acetyl-l-methionine a-naphthyl ester |
| (s)-naphthalen-1-yl 2-acetamido-4-(methylthio)butanoate |
| DTXSID50990225 |
| n-{4-(methylsulfanyl)-1-[(naphthalen-1-yl)oxy]-1-oxobutan-2-yl}ethanimidic acid |
| l-methionine,n-acetyl-,1-naphthalenyl ester |
| acetyl-l-methionine alpha-naphthyl ester |
| naphthalen-1-yl (2s)-2-acetamido-4-(methylsulfanyl)butanoate |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (5)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 5 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
Market Indicators
Research Demand Index: 12.66
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.66) All Compounds (24.57) |
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 5 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||